US Government To Buy Siga Technologies’ IV Antiviral Drug For Monkeypox Treatment

Reuters (8/9, Leo) reports, “The U.S. government will buy Siga Technologies Inc’s $26-million worth of intravenous formulation of antiviral drug Tpoxx [tecovirimat], the company said on Tuesday, as the country fights an outbreak of monkeypox cases.” Siga...